Collateral vessels reduce mortality

European Heart Journal

Volumn 33, Issue 5, 2012, Pages 564-566

  Schaper, W ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVENTITIA; ANGIOGENESIS; BLOOD VESSEL; COLLATERAL CIRCULATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; ENDOTHELIUM CELL; EPICARDIUM; HEART INFARCTION; HUMAN; MORTALITY; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM;

COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION;

EID: 84857938723     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr385     Document Type: Review

References (24)

1. Meier P, Hemingway H, Lansky AJ, Knapp G, Pitt B, Seiler C. The impact of the coronary collateral circulation on mortality: a meta-analysis. Eur Heart J 2012; 33:614-621.
2. Baroldi G, Scomazzoni G. Coronary Circulation in the Normal and the Pathological Heart. Washington, DC: Office of the Surgeon General, Department of the Army; 1967.
3. Fulton W. The morphology of coronary arterial anastomoses in health and disease and their influence on ischaemic myocardial damage. Acta Cardiol 1969; 12:38-67.
4. Schaper W, Schaper J. Arteriogenesis. Dordrecht: Kluwer Acadenic Publishers; 2004.
5. Helfant RH, Vokonas PS, Gorlin R. Functional importance of the human coronary collateral circulation. N Engl J Med 1971;284:1277-1281.
6. Wilkins DT, Helfant RH, Vokonas PS, Gorlin R. Coronary collateral circulation. N Engl J Med 1971;285:352-353.
7. Troidl K, Tribulova S, Cai WJ, Ruding I, Apfelbeck H, Schierling W, Troidl C, Schmitz-Rixen T, Schaper W. Effects of endogenous nitric oxide and of DETA NONOate in arteriogenesis. J Cardiovasc Pharmacol 2010;55:153-160.
8. Eitenmuller I, Volger O, Kluge A, Troidl K, Barancik M, Cai WJ, Heil M, Pipp F, Fischer S, Horrevoets AJ, Schmitz-Rixen T, Schaper W. The range of adaptation by collateral vessels after femoral artery occlusion. Circ Res 2006;99:656-662. (Pubitemid 44401457)
9. Pipp F, Boehm S, Cai WJ, Adili F, Ziegler B, Karanovic G, Ritter R, Balzer J, Scheler C, Schaper W, Schmitz-Rixen T. Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arterioscler Thromb Vasc Biol 2004;24:1664-1668. (Pubitemid 39180892)
10. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1998; 101:40-50. (Pubitemid 28058901)
11. Zbinden S, Zbinden R, Meier P, Windecker S, Seiler C. Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease. J Am Coll Cardiol 2005;46:1636-1642. (Pubitemid 41531615)
12. Meier P, Gloekler S, de Marchi SF, Indermuehle A, Rutz T, Traupe T, Steck H, Vogel R, Seiler C. Myocardial salvage through coronary collateral growth by granulocyte colony-stimulating factor in chronic coronary artery disease: a controlled randomized trial. Circulation 2009;120:1355-1363.
13. Hoefer IE, Piek JJ, Pasterkamp G. Pharmaceutical interventions to influence arteriogenesis: new concepts to treat ischemic heart disease. Curr Med Chem 2006;13: 979-987.
14. Cai W, Vosschulte R, Afsah-Hedjri A, Koltai S, Kocsis E, Scholz D, Kostin S, Schaper W, Schaper J. Altered balance between extracellular proteolysis and antiproteolysis is associated with adaptive coronary arteriogenesis. J Mol Cell Cardiol 2000;32:997-1011. (Pubitemid 30663107)
15. Cai WJ, Koltai S, Kocsis E, Scholz D, Kostin S, Luo X, Schaper W, Schaper J. Remodeling of the adventitia during coronary arteriogenesis. Am J Physiol Heart Circ Physiol 2003;284:H31-H40. (Pubitemid 36076267)
16. Dor Y, Djonov V, Abramovitch R, Itin A, Fishman GI, Carmeliet P, Goelman G, Keshet E. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J 2002;21:1939-1947. (Pubitemid 34437191)
17. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S, Chimenti S, Landsman L, Abramovitch R, Keshet E. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006;124:175-189. (Pubitemid 43069318)
18. Ignarro LJ, Napoli C. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr Atheroscler Rep 2004;6:281-287. (Pubitemid 39359467)
19. Maseri A, Fuster V. Is there a vulnerable plaque? Circulation 2003;107:2068-2071. (Pubitemid 36532183)
20. Schaper W. Expeimental infarcts and the microcirculation. In: Hearse DJ, Yello DM, eds. The Therapeutic Approaches to Myocardial Infarct Size Limitation. New York: Raven Press; 1984. p79-90.
21. SchaperW, De Brabander M, Lewi P. DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res 1971;28:671-679.
22. Boger RH, Vallance P, Cooke JP. Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase. Atheroscler Suppl 2003;4:1-3. (Pubitemid 38234488)
23. Boger RH, Maas R, Schulze F, Schwedhelm E. Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality. Clin Chem Lab Med 2005;43:1124-1129. (Pubitemid 41581972)
24. Fiedler LR, Bachetti T, Leiper J, Zachary I, Chen L, Renne T, Wojciak-Stothard B. The ADMA/DDAH pathway regulates VEGF-mediated angiogenesis. Arterioscler Thromb Vasc Biol 2009;29:2117-2124.